跳至主要内容
临床试验/NCT03280797
NCT03280797已完成不适用

Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases

Centre Hospitalier Universitaire de Nīmes4 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2017年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
4
主要终点
Dosage of cytokines between groups

研究概览

简要总结

This study will assess the feasibility of using cytokine expression profiles in blood samples as a method for evaluating rheumatoid polyarthritis

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient is at least 18 years old
  • Subjects included as patients have rheumatoid polyarthritis according to ACR EULA 2010, DAS28>3.2 criteria
  • Subjects included as controls are healthy volunteers who have no overexpression of cytokines

排除标准

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient has had at least 3 months of specific treatment that can potentially impact cytokine profile

结局指标

主要结局

Dosage of cytokines between groups

时间窗: Day 0

Concentration measured by ELISA and flow cytometry

次要结局

  • Creation of biobank(Day 0)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验